Clinical Trials Browser

INDUSTRY × Solid Tumors × Ramucirumab × Clear all

NCT02597036 2025-10-23

A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors

Phase 1 Terminated

62 enrolled 25 charts

Other solid neoplasm

Solid Tumors

NCT01634555 2019-02-26

A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI

Phase 2 Completed

29 enrolled 12 charts

Other solid neoplasm

Solid Tumors